Transfer from ciclosporin to mycophenolate-sirolimus immunosuppression for chronic renal disease after heart transplantation: safety and efficacy of two regimens.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Chronic kidney disease is common after heart transplantation, and is related to ciclosporin (CsA) therapy. We compared the safety and efficacy of two ciclosporin withdrawal regimens.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Nephrol. Dial. Transplant.

Title: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Publisher: Oxford University Press (OUP)

ISSN (Electronic): 1460-2385

ISSN (Print): 0931-0509

Publication date (Electronic): Dec 2009

Volume: 24

Issue: 12

Affiliations

[1 ] Department of Transplantation, Royal Brompton & Harefield NHS Trust (Harefield Hospital), Hill End Road, Harefield, Middlesex, UB9 6JH, UK.

Article

Publisher Item ID: gfp386

DOI: 10.1093/ndt/gfp386

PubMed ID: 19666660

SO-VID: 9ca6d365-0935-436c-82a0-5e06b38d0af2

History

Data availability:

Transfer from ciclosporin to mycophenolate-sirolimus immunosuppression for chronic renal disease after heart transplantation: safety and efficacy of two regimens.

Read this article at

Abstract

Related collections

Efficacy of Communicating Science

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 919

Cited by 1